{"id":"NCT00308581","sponsor":"UCB Pharma","briefTitle":"Certolizumab in Crohn's Disease Patients With Loss of Response or Intolerance to Infliximab","officialTitle":"Phase IIIb Open-label Induction and Double-blind Comparison of 2 Maintenance Schedules Evaluating Clinical Benefit and Tolerability of Certolizumab Pegol in Crohn's Disease Patients With Prior Loss of Response or Intolerance to Infliximab","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-04","primaryCompletion":"2008-04","completion":"2008-04","firstPosted":"2006-03-29","resultsPosted":"2009-11-17","lastUpdate":"2018-08-07"},"enrollment":539,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Crohn's Disease"],"interventions":[{"type":"BIOLOGICAL","name":"Certolizumab pegol","otherNames":["CDP870","Cimzia"]},{"type":"BIOLOGICAL","name":"Certolizumab pegol","otherNames":["CDP870","Cimzia"]},{"type":"OTHER","name":"Placebo","otherNames":[]}],"arms":[{"label":"Active 1","type":"EXPERIMENTAL"},{"label":"Active 2","type":"EXPERIMENTAL"}],"summary":"To assess the clinical efficacy of subcutaneous (sc) certolizumab pegol administration over 26 weeks in patients suffering from Crohn's Disease (CD) and previously treated with infliximab","primaryOutcome":{"measure":"Response Status With Response Defined as at Least 100 Point Decrease in Crohn's Disease Activity Score (CDAI Score) From Baseline in the Induction Phase","timeFrame":"Baseline to Week 6","effectByArm":[{"arm":"Overall","deltaMin":334,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":7},"locations":{"siteCount":107,"countries":["United States","Austria","Belgium","Canada","Denmark","France","Germany","Italy","Netherlands","Norway","Spain","Sweden","Switzerland","United Kingdom"]},"refs":{"pmids":["20925993","20451663","21223344"],"seeAlso":["http://www.fda.gov/Safety/MedWatch/SafetyInformation/default.htm"]},"adverseEventsSummary":{"seriousAny":{"events":25,"n":187},"commonTop":["Headache","Nausea","Nasopharyngitis","Pyrexia","Arthralgia"]}}